See also this year's filing and all EDGAR filings for this company.
PDF Report 0001044378_2019_Biocept_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001044378')"} |
Graph
Absolute values for 0001044378, Biocept INC
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 0 |
| 2 | AssetsCurrent | 6,010,881 |
| 3 | PropertyPlantAndEquipment | 2,739,422 |
| 4 | remainder_Assets | 0 |
| 5 | LongTermLiabilities | 0 |
| 6 | LiabilitiesCurrent | 4,609,647 |
| 7 | remainder_Liabilities | 1,098,137 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 10,051,735 |
| 10 | GeneralAndAdministrativeExpense | 7,074,024 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 5,914,706 |
| 15 | ResearchAndDevelopmentExpense | 4,468,572 |
| 16 | remainder_Expenses | 1,886 |
| 17 | remainder_Revenues | 3,250,298 |
| 18 | remainder_NetIncome | -310,976 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 8,750,303 |
| 1 | Liabilities | 5,707,784 |
| 2 | Expenses | 27,510,923 |
| 3 | Revenues | 3,250,298 |
| 4 | StockholdersEquity | 3,042,519 |
| 5 | NetIncome | -24,571,601 |
| 6 | ComprehensiveNetIncome | -24,571,601 |
| 7 | BaseVar | 22,765,142 |
| 8 | EconomicCapitalRatio | -2.23 |
Edgar->Model Mapping
Feature Distribution
Change over Time
